Autumn’s first cool mornings and increasingly early grape harvests in Central Europe serve as a brief, memorable clinical cue: review immunization records before the respiratory season and before 2026 travel plans...
1. GBS vaccine candidate clears a first key hurdle in HIV-endemic Africa A Ugandan phase 2 trial shows a hexavalent GBS6 vaccine candidate is safe and equally immunogenic in pregnant women with and without HIV, offering...
Why is there a medical need The outbreak that began in mid-May 2026 in the Democratic Republic of the Congo (DRC), with cross-border spread to Uganda, is caused by Bundibugyo ebolavirus (BDBV) — a species distinct from...
For three decades, the story of Haemophilus influenzae type b (Hib) has been held up as one of modern vaccinology’s cleanest victories. A bacterium that once filled pediatric wards with meningitis and epiglottitis...
Global outbreak status Cholera — multi-country. Cholera remains active globally and has worsened in the latest WHO update: 29,610 cholera/acute watery diarrhea cases and 271 deaths were reported from 16 countries or...
1. Vaccine research boomed with COVID — but it’s still a one-country show Summary: This systematic mapping and scientometric analysis (PRISMA 2020) searched PubMed, Scopus, and Web of Science for studies (January...
The most consequential active outbreak is the Bundibugyo virus Ebola disease in the Democratic Republic of Congo, while major ongoing risks also include mpox, cholera, meningitis-belt epidemics, vector-borne outbreaks...
1. Dengue antibodies play both hero and villain — and severity may tip the scales Vietnamese pediatric data show that the same antibody surge protecting children from repeat dengue may also be quietly loading the gun...